Similar findings, describing increased NRP1 levels in tumor tissue collected from gastric cancer [40], cervical cancer [42], NSCLC [45], bladder cancer [46], osteosarcoma [47], nasopharyngeal carcinoma [48], and renal cell carcinoma [52] have been reported. This evidence concerns the gene NRP1 and urinary bladder cancer.